Cargando…
Capromorelin oral solution (ENTYCE®) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study
BACKGROUND: Dogs can suffer from inappetence caused by a variety of medical conditions. This may present as anorexia (complete loss of appetite), hyporexia (decreased appetite) or dysrexia (change in food preferences). A drug with a new mechanism of action, capromorelin, has potential to stimulate a...
Autores principales: | Zollers, Bill, Rhodes, Linda, Heinen, Ernst |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217407/ https://www.ncbi.nlm.nih.gov/pubmed/28056951 http://dx.doi.org/10.1186/s12917-016-0925-z |
Ejemplares similares
-
A Prospective, Randomized, Masked, Placebo‐Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite
por: Zollers, B., et al.
Publicado: (2016) -
Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs
por: Rhodes, Linda, et al.
Publicado: (2017) -
Capromorelin, a ghrelin receptor agonist, increases feed intake and body weight gain in broiler chickens (Gallus gallus domesticus)
por: Ceron-Romero, N., et al.
Publicado: (2021) -
Toxicity Study of 28-Day Subcutaneous Injection of Arctigenin in Beagle Dogs
por: Li, Jie, et al.
Publicado: (2019) -
Cardiorespiratory and anesthetic effects produced by the combination of
butorphanol, medetomidine and alfaxalone administered intramuscularly in Beagle
dogs
por: LEE, Jongsung, et al.
Publicado: (2015)